reportingrisk.com← the monitorSEC reporting failures, scored and checked against what happened next

Or browse all companies A–Z.

Abvc Biopharma, Inc.

ABVC · Nasdaq

3 reporting failures in the last 12 months

Companies at this level ended the following year delisted, bankrupt, restated or silent 13.1% of the time, against 4.0% for companies with a clean record.

$37Mpublic float
2026-07-02most recent failure

Score over time

0123202220232024202520262023-01-01 · score 12022-10-21 auditor change2023-04-01 · score 12022-10-21 auditor change2023-07-01 · score 12022-10-21 auditor change2023-10-01 · score 12022-10-21 auditor change2024-01-01 · score 12023-11-14 filed late (10-Q) · accounts not ready2024-04-01 · score 12023-11-14 filed late (10-Q) · accounts not ready2024-07-01 · score 22024-05-15 filed late (10-Q) · accounts not ready2023-11-14 filed late (10-Q) · accounts not ready2024-10-01 · score 22024-05-15 filed late (10-Q) · accounts not ready2023-11-14 filed late (10-Q) · accounts not ready2025-01-01 · score 22024-10-18 auditor change2024-05-15 filed late (10-Q) · accounts not ready2025-04-01 · score 32025-03-31 filed late (10-K) · accounts not ready2024-10-18 auditor change2024-05-15 filed late (10-Q) · accounts not ready2025-07-01 · score 32025-04-15 accounts unreliable2025-03-31 filed late (10-K) · accounts not ready2024-10-18 auditor change2025-10-01 · score 32025-04-15 accounts unreliable2025-03-31 filed late (10-K) · accounts not ready2024-10-18 auditor change2026-01-01 · score 22025-04-15 accounts unreliable2025-03-31 filed late (10-K) · accounts not ready2026-04-01 · score 22026-03-03 accounts unreliable2025-04-15 accounts unreliable2026-07-01 · score 22026-05-15 filed late (10-Q) · XBRL or exhibits2026-03-03 accounts unreliable2026-10-01 · score 32026-07-02 auditor change2026-05-15 filed late (10-Q) · XBRL or exhibits2026-03-03 accounts unreliable

Hover or tap a dot to see the filings behind that score.

Why they said they were late

The Registrant is unable to finalize the Form 10-Q and XBRL exhibit to the report prior to the filing deadline without unreasonable effort or expense. Management reasonably believes that it will be able to complete and file the Form 10-Q Quarterly Report for March 31, 2026 within the prescribed extension period. SEC 1344 (05-06) Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number

NT 10-Q, filed 2026-05-15 · XBRL or exhibits

What it filed

2026-07-02auditor changed or resigned SEC →

2026-05-15filed late (10-Q)XBRL or exhibits SEC →

The Registrant is unable to finalize the Form 10-Q and XBRL exhibit to the report prior to the filing deadline without unreasonable effort or expense. Management reasonably believes that it will be able to complete and file the Form 10-Q Quarterly Report for March 31, 2026 within the prescribed extension period. SEC 1344 (05-06) Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number

2026-03-03accounts declared unreliable SEC →

2025-04-15accounts declared unreliable SEC →

2025-03-31filed late (10-K)accounts not ready SEC →

ABVC BioPharma, Inc. (the “Company”) is unable, without unreasonable effort or expense, to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2024 (the “Form 10-K”), by the filing deadline due to a delay experienced by the Company in completing its financial statements and other disclosures in the Form 10-K. As a result, the Company is still in the process of completing its audit for the fiscal year ended December 31, 2024 and compiling certain other required information for its Form 10-K. The Company anticipates that it will file the Form 10-K no later than the fifteenth calendar day following the prescribed filing date

2024-10-18auditor changed or resigned SEC →

2024-05-15filed late (10-Q)accounts not ready SEC →

The Registrant is unable to file its Quarterly Report on Form 10-Q for the period ended March 31, 2024 within the prescribed time period because it requires additional time for the review and completion of its financial statements. SEC 1344 (05-06) Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number

2023-11-14filed late (10-Q)accounts not ready SEC →

We could not timely file our Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2023, because the financial statements could not be completed in sufficient time to solicit and obtain the necessary review of the subject report and signatures thereto in a timely fashion prior to the due date of the report

2022-10-21auditor changed or resigned SEC →

About this score

reportingrisk.com scores every active US filer on three things a company tells the SEC about itself: late-filing notices on Form NT, 8-K item 4.02 (past accounts declared unreliable) and 4.01 (auditor changes). 1,012 are flagged today.

Every score is frozen and checked twelve months later. Across 91,452 of them, a company scoring 4 or more ended that year delisted, bankrupt, restated or silent 17.2% of the time, against 4.0% for a clean record. Scores before 2026-09-27 were reconstructed from the filing history as it stood at each date, so the record is a backtest rather than years of live calls.

See the ledger → Every company the score flagged that later failed, what it told the SEC on the way down, and the ones it missed.

Every item above is a filing this company made with the SEC.
Snapshot 2026-11-04 · data from SEC EDGAR (public domain) · not investment advice

reportingrisk.com← back to the monitorAll companies A-Z · RSS · found an error? hello@reportingrisk.com